Filter Results:
(1,328)
Show Results For
- All HBS Web
(1,328)
- People (1)
- News (334)
- Research (819)
- Events (1)
- Multimedia (8)
- Faculty Publications (591)
Show Results For
- All HBS Web
(1,328)
- People (1)
- News (334)
- Research (819)
- Events (1)
- Multimedia (8)
- Faculty Publications (591)
- Article
Biosimilars and Follow-On Products in the United States: Adoption, Prices, and Users
By: Ariel Dora Stern, Jacqueline L. Chen, Melissa Ouellet, Mark R. Trusheim, Zeid El-Kilani, Amber Jessup and Ernst R. Berndt
Biologic drugs account for a disproportionate share of the increase in pharmaceutical spending in the U.S. and worldwide. Against this backdrop, many look to the expanding market for biosimilars—follow-on products to biologic drugs—as a vehicle for controlling... View Details
Keywords: Pharmaceuticals; Drug Spending; Drug Pricing; Health Care and Treatment; Spending; Price; Markets; Cost Management; United States
Stern, Ariel Dora, Jacqueline L. Chen, Melissa Ouellet, Mark R. Trusheim, Zeid El-Kilani, Amber Jessup, and Ernst R. Berndt. "Biosimilars and Follow-On Products in the United States: Adoption, Prices, and Users." Health Affairs 40, no. 6 (June 2021): 989–999.
- Fast Answer
Student Proposed Fellowship Program - Resources for selecting your organization
The following resources can be used to identify nonprofit organizations: Identifying Organizations Search Strategies GuideStar Pro - Information about the missions, programs, and finances of more than 1.7 million nonprofit... View Details
- Profile
Kevin Nazemi
the Harvard Kennedy School “is the best of both worlds. I’m interested in the intersection of business, public policy, and technology, especially in health care. I see HBS as a place where you can dream big, and build the tool sets and... View Details
- June 2012 (Revised October 2018)
- Case
Home Nursing of North Carolina
By: Richard S. Ruback and Royce Yudkoff
Ari Medoff's (HBS '11) goal was to control his own professional destiny by owning his own company. His search identified a suitable acquisition in Home Nursing of North Carolina, and he had negotiated a purchase price of $3.5 million, or 4.2x trailing EBITDA. Medoff... View Details
Keywords: Search Funds; Small Companies; Acquisitions; Negotiation; Medical Services; Negotiation Process; Valuation; Investment; Acquisition; Health Industry
Ruback, Richard S., and Royce Yudkoff. "Home Nursing of North Carolina." Harvard Business School Case 212-120, June 2012. (Revised October 2018.)
- Web
Student Clubs | MBA
Family Business Club Finance Club FinTech Club First Generation Students Club Food and Agriculture Club Football/Soccer Club Formula One Club French-Speaking Club Future of Mobility Future of Work Club G Gaming and Game Industry Club... View Details
- Article
Time-Driven Activity-Based Costing in Breast Cancer Care Delivery
By: Navraj S. Nagra, Elena Tsangaris, Jessica Means, Michael J. Hassett, Laura S. Dominici, Jennifer R. Bellon, Justin Broyles, Robert S. Kaplan, Thomas W. Feeley and Andrea L. Pusic
We used time-driven activity-based costing (TDABC) to calculate the complete cost of breast cancer care—initial treatment planning, chemotherapy, radiation therapy, surgical resection and reconstruction, and ancillary services (psychosocial oncology, physical therapy.... View Details
Nagra, Navraj S., Elena Tsangaris, Jessica Means, Michael J. Hassett, Laura S. Dominici, Jennifer R. Bellon, Justin Broyles, Robert S. Kaplan, Thomas W. Feeley, and Andrea L. Pusic. "Time-Driven Activity-Based Costing in Breast Cancer Care Delivery." Annals of Surgical Oncology 29, no. 1 (January 2022): 510–521.
- fall 1994
- Article
Racing to Invest? The Dynamics of Competition in Ethical Drug Discovery
By: Rebecca M. Henderson and Ian Cockburn
Henderson, Rebecca M., and Ian Cockburn. "Racing to Invest? The Dynamics of Competition in Ethical Drug Discovery." Journal of Economics & Management Strategy 3, no. 3 (fall 1994): 481–519.
- July 2002
- Article
Asset Accumulation, Interdependence and Technological Change: Evidence from Pharmaceutical Drug Discovery
By: Stefan Thomke and Walter Kuemmerle
Thomke, Stefan, and Walter Kuemmerle. "Asset Accumulation, Interdependence and Technological Change: Evidence from Pharmaceutical Drug Discovery." Strategic Management Journal 23, no. 7 (July 2002): 619–635.
- 17 Oct 2006
- First Look
First Look: October 17, 2006
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=407025 Finance Leadership in Novartis Consumer Health Businesses Harvard Business School Case 406-102 Describes and contrasts the roles and... View Details
Keywords: Sean Silverthorne
- 06 Sep 2016
- News
Horse-Powered Healing
Finance strategist Elizabeth Coit (MBA 1991) took her career in an unexpected direction six years ago, when she became executive director of the Morning Dove Therapeutic Riding Center in Zionsville, Indiana. “At some point, I decided I... View Details
- Web
Creating Value Through Corporate Restructuring - Course Catalog
or crisis. This process of renegotiation and re-contracting - the “re-slicing of the corporate pie” - is the central focus of the course. An additional objective in dissecting the complex finances and operating challenges that confront... View Details
- August 1999
- Teaching Note
Dana-Farber Cancer Institute: Development Strategy, The (TN)
Teaching Note for (9-599-104). View Details
- Profile
Jonathon Bunt
bones of a new business.” Immediately after graduation, he returned to the San Francisco start-up and then, after a few months, formed a company of his own: Humble Brands. “It’s about beauty and health from within,” Jonathon says. “We... View Details
- 18 Feb 2016
- Blog Post
Honing an Interest in Healthcare at HBS
internship with a well-known healthcare expert organization to do some consulting work. I also took a class in health policy over at the Kennedy School, and spent quite a bit of time in and out of class with a small core of students from... View Details
- 15 Aug 2006
- First Look
First Look: August 15, 2006
expect bankers to have been less central than in Mexico and, perhaps, the United States. Second, I test if the availability of financing alternatives, like a well-developed bond market in Brazil, reduced the average importance of... View Details
Keywords: Sean Silverthorne
- 13 Dec 2016
- First Look
December 13, 2016
fundamental firm value, which is gradually revealed into prices. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=51971 December 2016 Harvard Business Review Health Care Needs Real Competition By: Dafny, Leemore S., and... View Details
Keywords: Carmen Nobel
- 2020
- Working Paper
Bankruptcy and the COVID-19 Crisis
By: Jialan Wang, Jeyul Yang, Benjamin Iverson and Raymond Kluender
We examine the impact of the COVID-19 economic crisis on business and consumer bankruptcies in the United States using real-time data on the universe of filings. Historically, bankruptcies have closely tracked the business cycle and contemporaneous unemployment rates.... View Details
Keywords: Bankruptcy; Financial Distress; COVID-19; Insolvency and Bankruptcy; Financial Crisis; Health Pandemics; United States
Wang, Jialan, Jeyul Yang, Benjamin Iverson, and Raymond Kluender. "Bankruptcy and the COVID-19 Crisis." Harvard Business School Working Paper, No. 21-041, September 2020.
- Fall 2020
- Article
Business Credit Programs in the Pandemic Era
By: Samuel G. Hanson, Jeremy C. Stein, Adi Sunderam and Eric Zwick
We develop a pair of models that speak to the goals and design of the sort of business-lending and corporate-bond purchase programs that have been introduced by governments in response to the ongoing COVID-19 pandemic. An overarching theme is that, in contrast to the... View Details
Keywords: COVID-19; Business Lending; Government Intervention; Econometric Models; Health Pandemics; Credit; Governance; Policy
Hanson, Samuel G., Jeremy C. Stein, Adi Sunderam, and Eric Zwick. "Business Credit Programs in the Pandemic Era." Brookings Papers on Economic Activity (Fall 2020).
- August 2020 (Revised December 2020)
- Case
Latam Airlines and COVID-19: Seeking Bankruptcy Protection in the United States
By: Laura Alfaro, Mauricio Larrain, Carlos Vilches and Sarah Jeong
On May 26, 2020, Latam Airlines became the largest airline in the world to be driven to bankruptcy by COVID-19. With a complex debt structure and international investor composition, the company decided to file for bankruptcy protection in the United States, which... View Details
Keywords: Airlines; Pandemic; Coronavirus Pandemic; Health Pandemics; Air Transportation; Insolvency and Bankruptcy; Capital Markets; Strategy; Latin America; Chile; United States
Alfaro, Laura, Mauricio Larrain, Carlos Vilches, and Sarah Jeong. "Latam Airlines and COVID-19: Seeking Bankruptcy Protection in the United States." Harvard Business School Case 321-027, August 2020. (Revised December 2020.)
- 19 May 2016
- Blog Post
5 Lessons from Business School
presentation or attending an academic review session, I chose the company presentation knowing that this choice aligned with my priorities. It helps to make those tough trade-off decisions a little easier. 4. You will not be the only person who did not take View Details